Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Portal versus systemic venous drainage of the pancreatic graft: the effect on glucose metabolism in pancreas and kidney transplant recipients

T. Havrdova, P. Boucek, T. Jedinakova, K. Lipar, M. Kocik, J. Skibova, F. Saudek,

. 2014 ; 46 (6) : 1910-1912.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031903

Grantová podpora
NT14020 MZ0 CEP - Centrální evidence projektů

Two different methods of graft venous drainage are used in pancreas transplantation: portal (PVD) and systemic (SVD). PVD is considered to be more physiologic due to its similarity to venous outflow of the native pancreas. The aim of our study was to compare glucose metabolism in Type 1 diabetic recipients of kidney and pancreatic grafts with PVD versus SVD by intravenous glucose tolerance test (IVGTT). We examined 28 insulin-independent patients after simultaneous pancreas and kidney transplantation: 14 recipients with PVD of the pancreatic graft and 14 with SVD after a mean post-transplant period of 1 year. All recipients had stable good function of the kidney graft. Fasting glycemia, insulin levels, glycosylated hemoglobin (HbA1c), and standard IVGTT with coefficient of glucose assimilation (KG) calculation were assessed. Insulin sensitivity and production were evaluated using the homeostasis model assessment (homeostasis model assessment of insulin resistance [HOMA-IR], homeostasis model assessment of B-cell function [HOMA-B]). Total C-peptide and insulin secretions were calculated as areas under the curves (AUCs) from the serum levels during the IVGTT. PVD and SVD groups did not differ in age, body mass index (BMI) and duration of post-transplantation period (P ≥ .05). We did not find any significant difference in fasting glycemia, HbA1c, KG, HOMA-IR, parameters of C-peptide level, fasting insulin level, and response during IVGTT. HOMA-B and AUC of insulin level were higher in the SVD group (45.1 ± 35.1 versus 19.8 ± 15.5, P =.03 and 1075 ± 612 versus 1799 ± 954 mIU/L/60 minutes, P < .03, respectively). In the PVD group, 1 patient had an abnormal response to the glucose stimulus, 8 patients had an impaired glucose tolerance, and 5 patients had a normal glucose tolerance. In the SVD group, an abnormal response was present in none, impaired glucose tolerance in 4, and normal glucose tolerance in 10 recipients. Athough this was not a prospectively randomized trial, we conclude that the change of surgical technique from SVD to PVD did not lead to any substantial change in terms of glucose tolerance.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031903
003      
CZ-PrNML
005      
20181214144430.0
007      
ta
008      
151005s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.transproceed.2014.05.073 $2 doi
035    __
$a (PubMed)25131068
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Havrdová, Terezia, $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: teje@medicon.cz. $d 1971- $7 xx0061179
245    10
$a Portal versus systemic venous drainage of the pancreatic graft: the effect on glucose metabolism in pancreas and kidney transplant recipients / $c T. Havrdova, P. Boucek, T. Jedinakova, K. Lipar, M. Kocik, J. Skibova, F. Saudek,
520    9_
$a Two different methods of graft venous drainage are used in pancreas transplantation: portal (PVD) and systemic (SVD). PVD is considered to be more physiologic due to its similarity to venous outflow of the native pancreas. The aim of our study was to compare glucose metabolism in Type 1 diabetic recipients of kidney and pancreatic grafts with PVD versus SVD by intravenous glucose tolerance test (IVGTT). We examined 28 insulin-independent patients after simultaneous pancreas and kidney transplantation: 14 recipients with PVD of the pancreatic graft and 14 with SVD after a mean post-transplant period of 1 year. All recipients had stable good function of the kidney graft. Fasting glycemia, insulin levels, glycosylated hemoglobin (HbA1c), and standard IVGTT with coefficient of glucose assimilation (KG) calculation were assessed. Insulin sensitivity and production were evaluated using the homeostasis model assessment (homeostasis model assessment of insulin resistance [HOMA-IR], homeostasis model assessment of B-cell function [HOMA-B]). Total C-peptide and insulin secretions were calculated as areas under the curves (AUCs) from the serum levels during the IVGTT. PVD and SVD groups did not differ in age, body mass index (BMI) and duration of post-transplantation period (P ≥ .05). We did not find any significant difference in fasting glycemia, HbA1c, KG, HOMA-IR, parameters of C-peptide level, fasting insulin level, and response during IVGTT. HOMA-B and AUC of insulin level were higher in the SVD group (45.1 ± 35.1 versus 19.8 ± 15.5, P =.03 and 1075 ± 612 versus 1799 ± 954 mIU/L/60 minutes, P < .03, respectively). In the PVD group, 1 patient had an abnormal response to the glucose stimulus, 8 patients had an impaired glucose tolerance, and 5 patients had a normal glucose tolerance. In the SVD group, an abnormal response was present in none, impaired glucose tolerance in 4, and normal glucose tolerance in 10 recipients. Athough this was not a prospectively randomized trial, we conclude that the change of surgical technique from SVD to PVD did not lead to any substantial change in terms of glucose tolerance.
650    _2
$a dospělí $7 D000328
650    _2
$a regulační B-lymfocyty $x imunologie $7 D060151
650    _2
$a C-peptid $x krev $7 D002096
650    _2
$a diabetes mellitus 1. typu $x metabolismus $7 D003922
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a glukózový toleranční test $7 D005951
650    _2
$a glykovaný hemoglobin $x analýza $7 D006442
650    _2
$a homeostáza $7 D006706
650    _2
$a lidé $7 D006801
650    _2
$a inzulin $x krev $7 D007328
650    12
$a transplantace ledvin $7 D016030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a transplantace slinivky břišní $7 D016035
650    _2
$a vena portae $7 D011169
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bouček, Petr, $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $d 1955-2015 $7 nlk20010095502
700    1_
$a Jedináková, Teodora, $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $d 1975- $7 xx0062088
700    1_
$a Lipar, K $u Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kočík, Matěj $u Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0244088
700    1_
$a Skibová, Jelena $u Statistical Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0061183
700    1_
$a Saudek, František, $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $d 1955- $7 nlk20000083698
773    0_
$w MED00004556 $t Transplantation proceedings $x 1873-2623 $g Roč. 46, č. 6 (2014), s. 1910-1912
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25131068 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20181214144557 $b ABA008
999    __
$a ok $b bmc $g 1092779 $s 915029
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 46 $c 6 $d 1910-1912 $i 1873-2623 $m Transplantation proceedings $n Transplant Proc $x MED00004556
GRA    __
$a NT14020 $p MZ0
LZP    __
$a Pubmed-20151005

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...